4D Molecular Therapeutics, Inc. Common Stock
XNAS:FDMT
10.7
$14.08 - 800.00
$10.00 - 260.00
$10.67
$11.5
$11.3
$11.19
12.34
2.24
478263
714302.1
50878178.06
Chart
TendieTensor AI Analysis
Company
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
Fundamentals
227
-2.720000
1.356300
-1.01
100
BBG00QG40R88
BBG00QG40S04
46.70M
46.70M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own FDMT. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.